7 terminated. 7 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Terminated 7 |
| Phase 2 | 1 | Terminated 1 |
Follow Hypercholesterolemia: new trials by email Literature Review of Hypercholesterolemia trials Research Report on Hypercholesterolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic and Pharmacodynamic Study of Bococizumab Alone and When Combined With Recombinant Human Hyaluronidase Cohort 1: bococizumab 150 mg + rHuPH20, Cohort 2: bococizumab 300 mg, Cohort 3: bococizumab 300 mg + rHuPH20 - Healthy, Hypercholesterolemia | Phase 1 | Terminated | Pfizer | 60 | 2016-02-01 | 2016-10-21 |
| Single Dose Study of PF-06815345 in Healthy Subjects PF-06815345, Placebo - Hypercholesterolemia | Phase 1 | Terminated | Pfizer | 25 | 2015-11-01 | 2018-09-28 |
| A Safety Study of BMS-852927 in Subjects With Hypercholesterolemia BMS-852927, Placebo - Hypercholesterolemia | Phase 1 | Terminated | Bristol-Myers Squibb | 97 | 2012-11-01 | 2013-08-05 |
| Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH SPC5001, Saline 0.9% - Hypercholesterolemia | Phase 1 | Terminated | Santaris Pharma A/S | 24 | 2011-05-01 | 2011-11-22 |
| Safety Study of BMS-844421 for Treatment of Hypercholesterolemia BMS-844421, 0.9% sodium chloride injection solution - Atherosclerosis, Hypercholesterolemia | Phase 1 | Terminated | Bristol-Myers Squibb | 40 | 2010-04-01 | 2011-01-26 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Liposomal siRNA in Subjects With High Cholesterol PRO-040201, Placebo - Hypercholesterolemia | Phase 1 | Terminated | Arbutus Biopharma Corporation | 23 | 2009-06-01 | 2010-01-22 |
| Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients 3,5-Diiodothyropropionic acid (DITPA) therapy - Hypercholesterolemia | Phase 1 / Phase 2 | Terminated | Johns Hopkins University | 60 | 2006-04-01 | 2013-04-02 |
Hyperlipidemias (2) · Atherosclerosis (1) · Coronary Artery Disease (1) · Dyslipidemias (1)
Lipid Metabolism Disorders (7) · Metabolic Diseases (7) · Nutritional and Metabolic Diseases (7) · Dyslipidemias (6) · Hyperlipidemias (5) · Arterial Occlusive Diseases (2) · Arteriosclerosis (2) · Cardiovascular Diseases (2) · Vascular Diseases (2) · Coronary Disease (1) · Heart Diseases (1) · Myocardial Ischemia (1)
3,5-diiodothyropropionic acid (1) · SPC5001 (1) · Sodium Chloride (1) · Therapeutics (1)
Bristol-Myers Squibb (2) · Pfizer (2) · Arbutus Biopharma Corporation (1) · Johns Hopkins University (1) · Santaris Pharma A/S (1)
Belgium (2) · Germany (2) · United States (2) · Canada (1) · Netherlands (1)
Annabelle Rodriguez, MD (1) · Douglas Logan, MD (1) · Koos Burggraaf, MD PhD (1)
2015 (2), 2009 (1)